The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Methoxy-5-(4-((2-(piperidin-1-yl)ethyl)amino)quinazolin-6-yl)benzamide ID: ALA4483535
PubChem CID: 155540773
Max Phase: Preclinical
Molecular Formula: C23H27N5O2
Molecular Weight: 405.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2ccc3ncnc(NCCN4CCCCC4)c3c2)cc1C(N)=O
Standard InChI: InChI=1S/C23H27N5O2/c1-30-21-8-6-17(14-19(21)22(24)29)16-5-7-20-18(13-16)23(27-15-26-20)25-9-12-28-10-3-2-4-11-28/h5-8,13-15H,2-4,9-12H2,1H3,(H2,24,29)(H,25,26,27)
Standard InChI Key: RYATVBKGMRPDSJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
5.4424 -4.5647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4413 -5.3842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1493 -5.7932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1475 -4.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8561 -4.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8569 -5.3801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5654 -5.7872 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2737 -5.3763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2690 -4.5542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5598 -4.1508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7367 -4.1564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7378 -3.3381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0308 -2.9298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3222 -3.3386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3251 -4.1600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0326 -4.5647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6139 -2.9311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6126 -2.1139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5555 -3.3337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2610 -2.9213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9643 -3.3265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6717 -2.9173 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3793 -3.3293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0846 -2.9236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0881 -2.1060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3801 -1.6959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6687 -2.1033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6189 -4.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9097 -4.1653 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6220 -5.3885 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
1 11 1 0
14 17 1 0
17 18 1 0
10 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
15 28 1 0
28 29 1 0
28 30 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 405.50Molecular Weight (Monoisotopic): 405.2165AlogP: 3.30#Rotatable Bonds: 7Polar Surface Area: 93.37Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.71CX Basic pKa: 8.76CX LogP: 2.70CX LogD: 1.32Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.63Np Likeness Score: -1.14
References 1. Hei YY, Xin M, Zhang H, Xie XX, Mao S, Zhang SQ.. (2016) Synthesis and antitumor activity evaluation of 4,6-disubstituted quinazoline derivatives as novel PI3K inhibitors., 26 (18): [PMID:27544401 ] [10.1016/j.bmcl.2016.08.015 ]